McKesson's Quarterly Earnings Preview: What You Need to Know McKesson will release its second-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth. Barchart · Oct 23
Dutch Police Hold Alleged ShinyHunters Leader, but Patients Hit by Health Vendor Breaches Still Face Scam Risks An alleged ShinyHunters leader is in Dutch custody. The arrest does not recover stolen patient data, so affected patients should stay alert for scams. Medical Daily · Oct 1
McKesson Narrows Confirmed Data Theft from Its Cyberattack to Oncology and Multispecialty Customers, Promises Patient Notices McKesson says confirmed data theft traces mainly to cancer and specialty practice customers. What patients should watch for as notices are prepared. Medical Daily · Sep 23
Multiple healthcare giants hit by data breaches affecting patient records, social security numbers, and even implanted cardiac devices Boston Scientific and McKesson are working on restoring services after being struck by disruptive cyberattacks. TechRadar · Sep 1
McKesson Stock Outlook: Is Wall Street Bullish or Bearish? McKesson has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects. Barchart · Aug 24
3 Healthcare Stocks With Fresh Dividend Hikes and Different Income Profiles McKesson, Encompass Health and Omega Healthcare Investors raised dividends, with payout ratios and yields showing varying levels of sustainability across the healthcare sector. MarketBeat · Aug 3
McKesson's Compounding Keeps Adding Up McKesson posted strong fiscal 2026 results, raised guidance, boosted buybacks and its dividend, and maintains a Moderate Buy rating from analysts amid its evolving specialty business mix. MarketBeat · Jul 31
McKesson's Q1 2027 Earnings: What to Expect McKesson is expected to announce its second-quarter earnings next month, and Wall Street forecasts a double-digit rise in its profits. Barchart · Jul 17
James Glassman's Top 30 Stock Picks Mid-Year Recap How dropping Nike for Costco could secure defensive wealth during 2026's market churn. Kiplinger · Jun 22
Is McKesson Stock Underperforming the Dow? McKesson has underperformed the Dow over the past year, but analysts are highly optimistic about the stock’s prospects. Barchart · Jun 3
Are Wall Street Analysts Predicting McKesson Stock Will Climb or Sink? McKesson has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects. Barchart · May 22
McKesson Q4 Earnings Call Highlights McKesson (NYSE:MCK) reported a stronger fiscal fourth quarter and full fiscal 2026 performance, with executives pointing to growth across its oncology, multispecialty, pharmaceutical distribution and prescription technology businesses, while outlining plans for continued earnings growth in fiscal 20 MarketBeat · May 11
McKesson Earnings Preview: What to Expect McKesson is expected to unveil its fourth-quarter results next month, and analysts are projecting a double-digit profit increase. Barchart · Apr 21
3 Stocks That Could Be Next to Announce a Stock Split Stock splits often follow strong growth. Here are three high-priced stocks that could be candidates for a stock split in 2026 MarketBeat · Mar 15
MarketBeat · Mar 6 3 Dividend Growth Stocks Quietly Raising Payouts Despite not having the highest dividend yields, these three firms may draw attention for their history of dividend growth and their strong overall performance.
Barchart · Mar 2 Is McKesson Corporation Stock Outperforming the Nasdaq? McKesson shows strong relative performance, with analysts maintaining a bullish outlook on its stock.
Barchart · Feb 17 Is Wall Street Bullish or Bearish on McKesson Stock? McKesson has outperformed the broader market over the past year, and analysts remain highly bullish about the stock’s prospects.
Kiplinger · Feb 5 Stocks Sink With Alphabet, Bitcoin: Stock Market Today A dismal round of jobs data did little to lift sentiment on Thursday.
The Independent UK · Jan 22 Texas man dies after pharmacy gives him another patient’s medication, lawsuit says Exclusive: Joseph Hamilton Broussard took the meds as directed, but he had received the wrong ones, the 91-year-old’s daughter alleges
Barchart · Nov 28, 2025 Is McKesson Corporation Stock Outperforming the S&P 500? McKesson has outstripped the S&P 500 Index's rally over the past year, igniting analysts’ unflinching optimism about the healthcare stock's steadfast, upward trajectory.
inkl · Nov 27, 2025 Digital Tools That Will Improve Your Workflow Efficiency In today’s fast-moving digital world, growth depends on more than hard work—it relies on the tools you choose. Whether you’re running marketing campaigns, tracking performance, automating repeatable tasks, or improving the way customers interact with your brand, the right digital setup can separate successful teams from those that struggle to…
Barchart · Nov 19, 2025 Are Wall Street Analysts Bullish on McKesson Stock? McKesson has outpaced the broader market returns over the past year, and analysts remain upbeat on MCK, noting the company’s reliable growth momentum and supportive earnings outlook.
Barchart · Oct 28, 2025 This ‘Strong Buy’ Healthcare Stock Just Hit New All-Time Highs McKesson (MCK) is trading at new all-time highs and has strong technical momentum. MCK has a 100% “Buy” opinion from Barchart. Shares are up nearly 60% over the past year. Analyst sentiment is overwhelmingly positive, with multiple “Strong Buy” ratings and price targets up to $984, despite some valuation concerns....
Barchart · Oct 22, 2025 What to Expect From McKesson's Next Quarterly Earnings Report McKesson is expected to announce its second-quarter results next month, and analysts predict a double-digit increase in the company’s bottom-line figure.
Barchart · Sep 13, 2025 The Saturday Spread: Picking Out Empirically Intriguing Stocks Potentially Due for a Comeback (MCK, HON, AKAM) It’s been another eventful week in the markets. These three stocks just might add some more excitement for contrarian bulls.